ArticleThe Journal of infectious diseases2017

Safety and Immunogenicity of PENNVAX-G DNA Prime Administered by Biojector 2000 or CELLECTRA Electroporation Device With Modified Vaccinia Ankara-CMDR Boost.

Julie A Ake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.